In response to several inquiries from journalists, the National Anti Doping Agency Germany (NADA) is providing information on the ongoing sports law proceedings in the Victoria Carl case.
On 3 April 2025, NADA Germany conducted an out-of-competition doping test on Victoria Carl. The subsequent analysis of the sample detected the substance clenbuterol (an anabolic substance) in the athlete's urine sample. As part of the results management procedure, the athlete made several statements to NADA Germany regarding the facts of the case and explained that the substance had entered her body as part of medical treatment with a cough syrup.
On September 22, 2025, NADA issued a so-called sanction notice with a proposed sanction of a two-year ban for a possible violation of anti-doping regulations. In the following period, NADA Germany and the athlete initially negotiated the amicable termination (‘dispute resolution agreement’) of the sports law proceedings, and since the beginning of November, in accordance with the provisions of the anti-doping regulations, with the involvement of World Anti-Doping Agency (WADA). The possibility of a dispute resolution agreement is expressly provided for in the anti-doping rules as a means of terminating proceedings in order to avoid lengthy and costly proceedings before national and international sports arbitration tribunals in individual cases. According to the provisions of the Anti-Doping Rules, WADA must always approve such an agreement. At the end of last week, WADA announced that it did not approve the conclusion of a dispute resolution agreement in this case.
In the further course of the proceedings, a decision will now be made on the acceptance of the sanction notice from September or the initiation of disciplinary proceedings before the German Sports Arbitration Court.